Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $79.32, but opened at $86.62. Sandoz Group shares last traded at $86.69, with a volume of 782 shares traded.
Wall Street Analyst Weigh In
Separately, Barclays raised Sandoz Group from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three investment analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Sandoz Group presently has a consensus rating of “Strong Buy”.
Read Our Latest Stock Analysis on Sandoz Group
Sandoz Group Price Performance
About Sandoz Group
Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.
The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.
Featured Stories
- Five stocks we like better than Sandoz Group
- Amprius Technologies Validates Growth Trajectory With Q2 Earnings—What Comes Next?
- Boeing’s Comeback Is Building Momentum—Is It Real?
- Blueprint for a Banking Fortress: Circle Redraws the Map
- Bed Bath & Beyond Renovates: The Neighborhood Blueprint
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
